Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Turnstone Biologics Q3 EPS $(1.00) Up From $(6.15) YoY; Cash, Cash Equivalents And Short-Term Investments $109.1M

Author: Benzinga Newsdesk | November 10, 2023 02:03am
Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(1.00) per share. This is a 83.74 percent increase over losses of $(6.15) per share from the same period last year.

Posted In: TSBX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist